Biotechnology entrepreneurship: leading, managing and commercializing innovative technologies
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
London
Academic Press, an imprint of Elsevier
[2020]
|
| Ausgabe: | Second edition |
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XXXIII, 648 Seiten Diagramme, Illustrationen |
| ISBN: | 9780128155851 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV046957072 | ||
| 003 | DE-604 | ||
| 005 | 20230428 | ||
| 007 | t | ||
| 008 | 201023s2020 ne a||| |||| 00||| eng d | ||
| 020 | |a 9780128155851 |c hardback |9 978-0-12-815585-1 | ||
| 035 | |a (DE-599)KXP1734968737 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a ne |c XA-NL |a xxu |c XD-US |a xxk |c XA-GB | ||
| 049 | |a DE-M382 | ||
| 050 | 0 | |a HD9999.B442 | |
| 082 | 0 | |a 338.76606025 |2 22 | |
| 082 | 0 | |a 338.4/766060684 |2 23 | |
| 084 | |a QP 230 |0 (DE-625)141847: |2 rvk | ||
| 084 | |a 58.30 |2 bkl | ||
| 084 | |a 83.67 |2 bkl | ||
| 245 | 1 | 0 | |a Biotechnology entrepreneurship |b leading, managing and commercializing innovative technologies |c edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| 250 | |a Second edition | ||
| 264 | 1 | |a London |b Academic Press, an imprint of Elsevier |c [2020] | |
| 300 | |a XXXIII, 648 Seiten |b Diagramme, Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |2 gnd |9 rswk-swf |
| 653 | 0 | |a Biotechnologie-Industrie / (DE-627)09135224X / (DE-STW)18260-5 | |
| 653 | 0 | |a Unternehmensgründung / (DE-627)091396514 / (DE-STW)12070-5 | |
| 653 | 0 | |a Humankapital / (DE-627)091366488 / (DE-STW)11224-2 | |
| 653 | 0 | |a Innovation / (DE-627)091367840 / (DE-STW)10459-1 | |
| 653 | 0 | |a Unternehmensfinanzierung / (DE-627)091359880 / (DE-STW)12205-1 | |
| 653 | 0 | |a Biotechnology industries / Management | |
| 653 | 0 | |a Entrepreneurship | |
| 689 | 0 | 0 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Shimasaki, Craig D. |0 (DE-588)1072650118 |4 edt | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032365492 | ||
Datensatz im Suchindex
| _version_ | 1804181873234018304 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Shimasaki, Craig D. |
| author2_role | edt |
| author2_variant | c d s cd cds |
| author_GND | (DE-588)1072650118 |
| author_facet | Shimasaki, Craig D. |
| building | Verbundindex |
| bvnumber | BV046957072 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9999 |
| callnumber-raw | HD9999.B442 |
| callnumber-search | HD9999.B442 |
| callnumber-sort | HD 49999 B442 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QP 230 |
| ctrlnum | (DE-599)KXP1734968737 |
| dewey-full | 338.76606025 338.4/766060684 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.76606025 338.4/766060684 |
| dewey-search | 338.76606025 338.4/766060684 |
| dewey-sort | 3338.76606025 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| edition | Second edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01842nam a2200469 c 4500</leader><controlfield tag="001">BV046957072</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230428 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">201023s2020 ne a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128155851</subfield><subfield code="c">hardback</subfield><subfield code="9">978-0-12-815585-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1734968737</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">ne</subfield><subfield code="c">XA-NL</subfield><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield><subfield code="a">xxk</subfield><subfield code="c">XA-GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9999.B442</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.76606025</subfield><subfield code="2">22</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/766060684</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QP 230</subfield><subfield code="0">(DE-625)141847:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.30</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">83.67</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biotechnology entrepreneurship</subfield><subfield code="b">leading, managing and commercializing innovative technologies</subfield><subfield code="c">edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States)</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">[2020]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXXIII, 648 Seiten</subfield><subfield code="b">Diagramme, Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnologie-Industrie / (DE-627)09135224X / (DE-STW)18260-5</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Unternehmensgründung / (DE-627)091396514 / (DE-STW)12070-5</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Humankapital / (DE-627)091366488 / (DE-STW)11224-2</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Innovation / (DE-627)091367840 / (DE-STW)10459-1</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Unternehmensfinanzierung / (DE-627)091359880 / (DE-STW)12205-1</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnology industries / Management</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Entrepreneurship</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shimasaki, Craig D.</subfield><subfield code="0">(DE-588)1072650118</subfield><subfield code="4">edt</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032365492</subfield></datafield></record></collection> |
| id | DE-604.BV046957072 |
| illustrated | Illustrated |
| index_date | 2024-07-03T15:42:51Z |
| indexdate | 2024-07-10T08:58:34Z |
| institution | BVB |
| isbn | 9780128155851 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032365492 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | XXXIII, 648 Seiten Diagramme, Illustrationen |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Academic Press, an imprint of Elsevier |
| record_format | marc |
| spelling | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) Second edition London Academic Press, an imprint of Elsevier [2020] XXXIII, 648 Seiten Diagramme, Illustrationen txt rdacontent n rdamedia nc rdacarrier Literaturangaben Biotechnologische Industrie (DE-588)4208106-3 gnd rswk-swf Biotechnologie-Industrie / (DE-627)09135224X / (DE-STW)18260-5 Unternehmensgründung / (DE-627)091396514 / (DE-STW)12070-5 Humankapital / (DE-627)091366488 / (DE-STW)11224-2 Innovation / (DE-627)091367840 / (DE-STW)10459-1 Unternehmensfinanzierung / (DE-627)091359880 / (DE-STW)12205-1 Biotechnology industries / Management Entrepreneurship Biotechnologische Industrie (DE-588)4208106-3 s DE-604 Shimasaki, Craig D. (DE-588)1072650118 edt |
| spellingShingle | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies Biotechnologische Industrie (DE-588)4208106-3 gnd |
| subject_GND | (DE-588)4208106-3 |
| title | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_auth | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_exact_search | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_exact_search_txtP | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_full | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| title_fullStr | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| title_full_unstemmed | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| title_short | Biotechnology entrepreneurship |
| title_sort | biotechnology entrepreneurship leading managing and commercializing innovative technologies |
| title_sub | leading, managing and commercializing innovative technologies |
| topic | Biotechnologische Industrie (DE-588)4208106-3 gnd |
| topic_facet | Biotechnologische Industrie |
| work_keys_str_mv | AT shimasakicraigd biotechnologyentrepreneurshipleadingmanagingandcommercializinginnovativetechnologies |